PaxMedica Inc. Common Stock (PXMD)

PaxMedica Inc. Common Stock (PXMD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $88,385; returns 1 day +40.0%.

PaxMedica Inc. (PXMD) is a clinical-stage biopharmaceutical company dedicated to developing novel anti-purinergic drug therapies (APTs) for central nervous system disorders, with a particular emphasis on unmet medical needs in autism spectrum disorder (ASD), mood disorders, and related behavioral conditions.

Groups PXMD belongs to

• Biotechnology
• Clinical Stage Biotech
• Pharmaceuticals
• Biopharmaceutical
• CNS Disorders
• Neuroscience
• Unmet Medical Needs
• Healthcare
• Neurological Disorders
• Clinical Stage
• Rare Diseases

PXMD financial model: income statement, cash flow and balance sheet